Phase II trial of pemetrexed in second line advanced/metastatic osteosarcomas.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2013
At a glance
- Drugs Pemetrexed (Primary)
- Indications Osteosarcoma
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 24 Jun 2011 Actual end date changed from Apr 2010 to Jun 2010 as reported by ClinicalTrials.gov.
- 31 Aug 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.